ORMP
NASDAQ · Pharmaceuticals
Oramed Pharmaceuticals Inc
$4.11
-0.12 (-2.84%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+132.4% upside
Low Target
$5.95
Average Target
$9.55
High Target
$10.69
Current Price
$4.11
Current
$4.11
$4.11
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69
Scenario Analysis
Bear Case
$5.95
44.8%
Low target
Base Case
$9.55
+132.4%
Avg target
Bull Case
$10.69
+160.1%
High target
Risk/Reward
3.6x
Highly favorable
Price in Context
52-Week High
$5.47
-24.9% from high
52-Week Low
$2.09
+96.7% from low
Target vs 52W High
$9.55
+74.6% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $0.44
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals